Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.5 CAD | 0.00% | 0.00% | +53.43% |
Mar. 15 | Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024 | |
Mar. 14 | Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023. | CI |
Sales 2024 * | 28.87M 21.11M | Sales 2025 * | 29.33M 21.44M | Capitalization | 205M 150M |
---|---|---|---|---|---|
Net income 2024 * | 12M 8.77M | Net income 2025 * | 13M 9.5M | EV / Sales 2024 * | 7.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.99 x |
P/E ratio 2024 * |
17.3
x | P/E ratio 2025 * |
19.6
x | Employees | 5 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.49% |
Latest transcript on Cipher Pharmaceuticals Inc.
Current month | -4.49% | ||
1 month | -10.53% | ||
3 months | +47.83% | ||
6 months | +89.73% | ||
Current year | +53.43% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Mull
CEO | Chief Executive Officer | - | 19-03-25 |
Bryan Jacobs
DFI | Director of Finance/CFO | - | 22-08-14 |
James Bowen
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harold Wolkin
BRD | Director/Board Member | 72 | 16-08-07 |
Douglas N. Deeth
BRD | Director/Board Member | 76 | 23-06-20 |
Craig Mull
CEO | Chief Executive Officer | - | 19-03-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 8.5 | 0.00% | 3,900 |
24-04-25 | 8.5 | -0.12% | 19,724 |
24-04-24 | 8.51 | -3.41% | 14,834 |
24-04-23 | 8.81 | +5.01% | 52,559 |
24-04-22 | 8.39 | -1.29% | 10,586 |
Delayed Quote Toronto S.E., April 26, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.43% | 150M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- CPH Stock